Skip to content

Genetics, environment and prevention

TL;DR — Asthma susceptibility is polygenic and exposure-dependent: a 22-biobank multi-ancestry GWAS of 153,763 cases and 1,647,022 controls identified 179 loci, 49 not previously reported, but individual common variants have small effects and do not diagnose asthma (Tsuo 2022, PMID 36778051). The childhood 17q21 signal is among the most reproducible; meta-analysis associated rs7216389 with pediatric asthma at OR 1.41 (95% CI 1.34–1.49), far below deterministic risk (Qu 2018, PMID 28006895). Environmental risks include tobacco smoke, traffic pollution, occupational sensitizers, obesity and viral wheezing, while traditional farm microbial exposures are associated with protection. Traffic-pollution meta-analysis estimated childhood-asthma risks per exposure increment of RR 1.05 (1.02–1.07) for 4 μg/m³ NO2 and RR 1.03 (1.01–1.05) for 1 μg/m³ PM2.5 (Khreis 2017, PMID 27881237). Despite many associations, there is no universal primary-prevention package: exposure reduction is justified for health, but vitamin, probiotic and allergen-avoidance interventions have not consistently prevented school-age asthma.

A causal model

Asthma arises when inherited susceptibility, developmental timing and exposure produce a persistent tendency to variable airway obstruction. None of these layers is sufficient alone.

Layer Examples What can be inferred
Germline susceptibility 17q21/ORMDL3-GSDMB, IL33/IL1RL1, TSLP, HLA and epithelial/immune loci Population risk and biological hypotheses, not individual diagnosis (Ober 2016, PMID 27027959)
Development Fetal lung growth, immune maturation, airway caliber, early microbiome Critical windows may amplify or buffer later exposure
Sensitization Allergens, occupational proteins/chemicals Can create antigen-specific disease but not all sensitized people develop asthma
Irritant and climate exposure Smoke, NO2, particulate matter, ozone, wildfire smoke, heat/cold Can cause attacks and may contribute to incidence; exposure mixtures complicate attribution
Infection RSV, rhinovirus and other respiratory viruses Trigger attacks and associate with later asthma; causal direction and shared predisposition coexist
Social structure Housing, work, transport, care access and environmental regulation Determines dose, ability to avoid exposure and consequences once disease develops

The same exposure can affect incidence, exacerbation and lung-function trajectory through different pathways. Prevention studies must specify which outcome they target.

Genetic architecture

The Global Biobank Meta-analysis Initiative combined 22 biobanks across ancestries: 153,763 asthma cases and 1,647,022 controls. It found 179 associated loci, including 49 not previously reported; effect directions were largely consistent across biobanks and ancestries, while the authors showed that greater ancestral diversity improved non-European polygenic prediction (Tsuo 2022, PMID 36778051).

Genetic finding Quantitative/functional anchor Limitation
Polygenic architecture 179 loci in the 2022 multi-ancestry meta-analysis Case definitions differ; common loci explain only a fraction of individual risk (Tsuo 2022, PMID 36778051)
17q21 rs7216389 10 studies, 7,797 cases/38,757 controls: pediatric asthma OR 1.41 (95% CI 1.34–1.49); atopic asthma OR 1.45 (1.22–1.72) Linkage region contains multiple genes and regulatory effects (Qu 2018, PMID 28006895)
ORMDL3/GSDMB Expression and experimental work links the locus to sphingolipids, stress responses, remodeling and pyroptosis-related biology Model effects do not establish which gene mediates each human association (Das 2017, PMID 28826527)
IL33/IL1RL1 and TSLP Repeated association with type-2/allergic susceptibility Alleles do not map one-to-one to biomarker-defined endotypes (Ntontsi 2021, PMID 33673725)
Shared architecture Genetic overlap between age-at-onset groups and asthma comorbidities Genetic correlation is not clinical identity (Tsuo 2022, PMID 36778051)

GWAS associations are usually regulatory, cell-specific and context-dependent. Post-GWAS work must connect variant → gene regulation → relevant airway/immune cell → exposure response → clinical phenotype (Ober 2016, PMID 27027959).

Polygenic risk scores remain research tools. Their calibration depends on ancestry, phenotype definition and source population; improved discrimination does not by itself show that screening improves outcomes.

Epigenetics and gene–environment interaction

DNA methylation, histone state and microRNA expression change with cell type, age, inflammation and exposure. Cross-sectional differences between asthma and controls can be causes, consequences of disease, or effects of corticosteroid treatment (Ntontsi 2021, PMID 33673725).

Gene–environment interaction studies are statistically demanding because both allele and exposure effects are modest, exposure measurement is noisy and multiple testing is large. A review found the literature on smoke, air pollution and endotoxin interactions inconclusive and emphasized larger cooperative studies with better phenotyping (London 2009, PMID 18980546).

The prevention implication is restraint: a genetic association can prioritize a pathway, but it does not identify a proven exposure intervention or a clinically useful high-risk infant by itself.

Viral wheeze: marker, mediator or both?

Severe infant bronchiolitis and later asthma are associated, but shared airway/immune susceptibility can make infection both a mediator and an early marker.

Evidence Result Interpretation
Direct virus comparison meta-analysis 38 studies; rhinovirus bronchiolitis vs RSV bronchiolitis: recurrent wheeze OR 4.11 (95% CI 2.24–7.56), later asthma OR 2.72 (1.48–4.99) Virus identity and host predisposition matter; comparison is among infants already ill enough for bronchiolitis (Makrinioti 2022, PMID 35338734)
INSPIRE birth cohort 1,741 infants with RSV status; asthma at age five in 16% without vs 21% with infant RSV infection Prospectively ascertained natural infection; association does not prove that preventing RSV prevents asthma (Rosas-Salazar 2023, PMID 37086744)
Mechanistic synthesis Rhinovirus wheeze enriched with atopy and altered interferon biology Infection may expose a pre-existing asthma-prone state (Jartti 2011, PMID 21535176)

RSV immunoprophylaxis and vaccines can prevent RSV disease, but asthma prevention requires trials with sufficiently long follow-up and definitions separating recurrent wheeze from objectively supported school-age asthma.

Tobacco and inhaled exposures

Secondhand smoke meta-analysis of 20 studies produced a pooled OR of 1.32 (95% CI 1.23–1.42) for physician-diagnosed childhood asthma, with I²=74.2%, showing a modest association with substantial heterogeneity (Tinuoye 2013, PMID 23539174).

An EAACI evidence review found moderate-certainty evidence that prenatal environmental tobacco smoke increases recurrent wheeze and that postnatal exposure increases new-onset asthma and recurrent wheeze. Among people with asthma, environmental smoke increased severe-exacerbation risk and worsened control and lung function; evidence on e-cigarettes was sparse (Agache 2024, PMID 38783343).

Active smoking complicates diagnosis, accelerates lung-function loss, weakens corticosteroid responsiveness and increases severe-exacerbation risk. Smoking avoidance is therefore primary, secondary and tertiary prevention simultaneously.

Ambient pollution and climate

Exposure and outcome Pooled estimate Source
Childhood asthma per 0.5×10⁻⁵ m⁻¹ black carbon RR 1.08 (95% CI 1.03–1.14) 41-study systematic review, Khreis 2017, PMID 27881237
Childhood asthma per 4 μg/m³ NO2 RR 1.05 (1.02–1.07) Khreis 2017, PMID 27881237
Childhood asthma per 1 μg/m³ PM2.5 RR 1.03 (1.01–1.05) Khreis 2017, PMID 27881237
Adult-onset asthma per 5 μg/m³ PM2.5 RR 1.07 (1.01–1.13) 25-study review, Lee 2024, PMID 39674196
Adult-onset asthma per 10 μg/m³ NO2 RR 1.11 (1.03–1.20) Lee 2024, PMID 39674196

These increments are not interchangeable across pollutants or studies. Exposure models, residential mobility, co-pollutants and asthma definitions contribute heterogeneity.

Short-term PM2.5, PM10 and NO2 exposure probably increases asthma hospitalization and ED risk; traffic may worsen control, while heatwaves and cold spells may increase acute-care and mortality risk, with lower-certainty evidence (Agache 2024, PMID 38311978).

Wildfire smoke combines intense particulate exposure with gases and displacement. Increasing fire seasons change both peak exposure and geographic reach, making clean-air shelter, filtration and occupational protection part of adaptation policy (Balmes 2023, PMID 37739070).

Occupational asthma

Occupational asthma is asthma caused by work exposure; work-exacerbated asthma is pre-existing or coincident asthma worsened at work. The distinction matters for compensation and exposure removal but can be difficult after a worker leaves the exposure (Tarlo 2014, PMID 24521110).

Exposure class Examples Evidence/response
High-molecular-weight sensitizers Flour, animal proteins, enzymes, latex Specific IgE/skin testing can support sensitization; serial work/off-work physiology establishes relation (Jolly 2015, PMID 26461873)
Low-molecular-weight sensitizers Isocyanates, acrylates, anhydrides Immunologic tests are less reliable; specialist challenge may be required
Irritants Chlorine, cleaning agents, smoke High-level acute exposure or repeated irritant exposure can cause/worsen asthma
Wood bioaerosol Dust, allergens, endotoxin, β-glucan and processing chemicals Reported asthma prevalence 6–18% and rhinitis 16–33% among wood workers across studies (Baatjies 2023, PMID 36821481)

In a Swedish population sample, flour dust exposure was associated with physician-diagnosed adult-onset asthma at OR 2.8 (95% CI 1.5–5.2) and resin-paint/isocyanate handling at OR 3.0 (1.6–5.9) (Torén 1999, PMID 10569463).

Removal from the causal exposure offers the highest probability of improvement but may not produce full recovery and can impose income loss. Prevention should prioritize substitution, enclosure, ventilation and exposure monitoring before reliance on personal protective equipment (Jolly 2015, PMID 26461873).

The farm effect and microbiome

Children raised in traditional livestock-farm environments have lower allergic asthma risk in multiple cohorts. Amish and Hutterite comparisons—groups with related ancestry but different farming practices—link differences in house-dust endotoxin, innate immune profiles and asthma prevalence to microbial exposure rather than a generic rural label (Ober 2017, PMID 28843541).

The farm effect does not justify deliberate exposure to raw farm dust. Protective components, dose, timing and safety remain unresolved.

Gut and airway microbiome associations are strongest in early life, but antibiotics, diet, infection and asthma treatments confound composition. Human probiotic and microbiome-restoration studies have not established an asthma-prevention therapy (Hufnagl 2020, PMID 32072252; Smits 2016, PMID 26947981).

Allergens and sensitization

Sensitization, exposure and symptoms must be distinguished. Removing an allergen to which a person is not sensitized is unlikely to change allergic asthma; even in sensitized disease, single-component avoidance often fails because exposure is persistent and multiple triggers coexist.

Multicomponent housing interventions can reduce exposure and morbidity in selected high-risk children, but established-asthma attack prevention is not the same as preventing asthma onset.

Allergen immunotherapy can modify allergic disease in selected patients, yet primary prevention of asthma remains product-, allergen- and population-specific and is constrained by safety in uncontrolled asthma (Abramson 2003, PMID 14583928).

Nutrition and primary-prevention trials

Candidate intervention Current signal Why it is not a general recommendation
Higher-dose vitamin D in pregnancy Some reduction in early-childhood wheeze Effect does not consistently persist to school-age asthma; trials differ in baseline status and dose (Nuzzi 2022, PMID 35215404)
Omega-3 fatty acids in pregnancy/infancy Possible wheeze reduction in some studies Results conflict and may depend on background diet or genotype (Nuzzi 2022, PMID 35215404)
Probiotics Changes microbial composition and some allergic outcomes Reviews and human studies retrieved in a 2026-08-30 primary-prevention re-query did not establish a consistent asthma-prevention effect (Hufnagl 2020, PMID 32072252)
Broad allergen avoidance Biologically plausible for sensitization Complex interventions, adherence and exposure substitution limit inference
Breastfeeding Multiple established benefits and observational asthma associations Residual confounding and heterogeneous asthma ages/definitions prevent a simple causal effect estimate

The first 1,000 days may be a critical window, but evidence quality is insufficient to prescribe a specific diet solely to prevent asthma (Nuzzi 2022, PMID 35215404).

Prevention hierarchy

Level Target Evidence-based examples
Primary Prevent disease onset Tobacco-smoke prevention; workplace sensitizer control; air-quality policy; healthy-weight support; investigational early-life interventions (Koppelman 2025, PMID 41038211)
Secondary Detect disease and prevent progression/attacks Objective diagnosis, exposure attribution, early ICS-containing treatment, occupational removal
Tertiary Prevent disability and death Attack plans, adherence support, biologics for eligible severe disease, steroid-harm reduction

GBD 2021 attributed 29.9% of asthma DALYs to high BMI, occupational asthmagens, smoking and NO2 combined, making policy-level exposure control a material prevention strategy even without perfect causal allocation for each case (GBD 2021 Asthma and Allergic Diseases Collaborators 2025, PMID 40147466).

Open questions

  • Which early-life viral-prevention intervention reduces objectively confirmed school-age asthma rather than only bronchiolitis and preschool wheeze? (Rosas-Salazar 2023, PMID 37086744)
  • Can protective farm-associated microbial products be identified and delivered safely without recreating hazardous exposure? (Ober 2017, PMID 28843541)
  • Do ancestry-calibrated polygenic scores improve prevention enough to justify screening, and in which health system? (Tsuo 2022, PMID 36778051)
  • Which pollution intervention produces a measurable reduction in incident asthma, beyond short-term attack reduction? (Lee 2024, PMID 39674196)
  • What combination of substitution, surveillance and income protection prevents occupational asthma without shifting risk to precarious workers? (Jolly 2015, PMID 26461873)
  • Which nutritional signal, if any, survives to objectively defined school-age asthma? (Nuzzi 2022, PMID 35215404)

References

  1. Tsuo K, et al. Multi-ancestry meta-analysis of asthma identifies novel associations and highlights the value of increased power and diversity. Nat Genet. 2022. PMID 36778051
  2. Ober C, Yao TC. Asthma genetics in the post-GWAS era. Ann Am Thorac Soc. 2016;13 Suppl 1:S85-90. PMID 27027959
  3. Ntontsi P, et al. Genetics and epigenetics in asthma. Int J Mol Sci. 2021;22:2412. PMID 33673725
  4. Qu YL, et al. 17q21 locus rs7216389 polymorphism and childhood asthma risk: a meta-analysis. Pediatr Allergy Immunol Pulmonol. 2018. PMID 28006895
  5. Das S, et al. Chromosome 17q21 genes ORMDL3 and GSDMB in asthma and immune diseases. Adv Immunol. 2017;135:1-52. PMID 28826527
  6. London SJ, Romieu I. Gene by environment interaction in asthma. Annu Rev Public Health. 2009;30:55-80. PMID 18980546
  7. Makrinioti H, et al. RSV- and rhinovirus-induced bronchiolitis in recurrent wheeze and asthma: systematic review and meta-analysis. Pediatr Allergy Immunol. 2022. PMID 35338734
  8. Rosas-Salazar C, et al. Respiratory syncytial virus infection during infancy and asthma during childhood: INSPIRE. Lancet. 2023;401:1669-1680. PMID 37086744
  9. Jartti T, et al. Rhinovirus-induced bronchiolitis and asthma development. Pediatr Allergy Immunol. 2011;22:350-355. PMID 21535176
  10. Tinuoye O, et al. Secondhand smoke exposure and physician-diagnosed childhood asthma: meta-analysis. Nicotine Tob Res. 2013;15:1475-1483. PMID 23539174
  11. Agache I, et al. Tobacco smoke and e-cigarettes on asthma-related outcomes: systematic review for EAACI guidelines. Allergy. 2024. PMID 38783343
  12. Khreis H, et al. Traffic-related air pollution and childhood asthma development: systematic review and meta-analysis. Environ Int. 2017;100:1-31. PMID 27881237
  13. Lee S, et al. Ambient air pollution exposure and adult asthma incidence: systematic review and meta-analysis. Lancet Planet Health. 2024. PMID 39674196
  14. Agache I, et al. Outdoor pollution and extreme temperatures on asthma-related outcomes: systematic review for EAACI guidelines. Allergy. 2024. PMID 38311978
  15. Balmes JR. Increasing wildfire smoke from the climate crisis: impacts on asthma and allergies. J Allergy Clin Immunol. 2023. PMID 37739070
  16. Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014;370:640-649. PMID 24521110
  17. Jolly AT, et al. Work-related asthma. J Occup Environ Med. 2015;57:e121-e129. PMID 26461873
  18. Torén K, et al. Adult-onset asthma and occupational exposures. Scand J Work Environ Health. 1999;25:430-435. PMID 10569463
  19. Baatjies R, et al. Wood dust and asthma. Curr Opin Allergy Clin Immunol. 2023. PMID 36821481
  20. Ober C, et al. Immune development and environment: lessons from Amish and Hutterite children. Curr Opin Immunol. 2017;48:51-60. PMID 28843541
  21. Hufnagl K, et al. Dysbiosis of the gut and lung microbiome has a role in asthma. Semin Immunopathol. 2020;42:75-93. PMID 32072252
  22. Smits HH, et al. Microbes and asthma: opportunities for intervention. J Allergy Clin Immunol. 2016;137:690-697. PMID 26947981
  23. Abramson MJ, et al. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2003. PMID 14583928
  24. Nuzzi G, et al. Primary prevention of pediatric asthma through nutritional interventions. Nutrients. 2022;14. PMID 35215404
  25. Curtis EM, et al. Maternal vitamin D supplementation during pregnancy. Br Med Bull. 2018. PMID 29684104
  26. Garden FL, et al. Cohort profile: the Childhood Asthma Prevention Study. Int J Epidemiol. 2018. PMID 29800224
  27. Koppelman GH, et al. Genetic and environmental risk factors for asthma: towards prevention. Lancet. 2025. PMID 41038211
  28. GBD 2021 Asthma and Allergic Diseases Collaborators. Global burden of asthma and atopic dermatitis, 1990–2021. Lancet Respir Med. 2025. PMID 40147466
  29. Toskala E, Kennedy DW. Asthma risk factors. Int Forum Allergy Rhinol. 2015;5 Suppl 1:S11-S16. PMID 26335830